Benign symmetrical lipomatosis (peripheral lipodystrophy) during antiretroviral treatment of HIV infection

被引:6
作者
Fischer, T [1 ]
Schwörer, H [1 ]
Ramadori, G [1 ]
机构
[1] Univ Gottingen, Med Klin, Zentrum Innere Med, Abt Gastroenterol & Endokrinol, D-37075 Gottingen, Germany
关键词
D O I
10.1055/s-2007-1024217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
History and admission findings: A 29-year-old hemophiliac with HIV infection for which he was receiving antiretroviral treatment (ART) with indinavir, zidovudin and zalcitabin reported increasing swelling of the neck. Physical examination noted a soft to doughy swelling, not sensitive to pressure, extending from the neck to between the shoulder blades. Investigations: Ultrasonography and magnetic resonance imaging revealed the swelling to consist of an accumulation of subcutaneous fat without capsule. Cytology demonstrated benign fatty tissue. Blood triglycerides totalled 667 mg/dl. Diagnosis, treatment and course: The typical location, absence of a capsule and the cytological finding confirmed the clinical diagnosis of drug-induced benign symmetrical lipomatosis (BSL, also called peripheral lipodystrophy) in ART. A connection with the hyperlipoproteinaemia is supported by the observation that the patient used to have a normal fat metabolism; the onset of BSL coincided with a massive increase in triglyceride levels. The hyperglyceridaemia and clinical signs improved on a low-fat diet. Conclusions: BSL can occur in the course of ART in HIV infection, when reverse-transcriptase inhibitors or protease inhibitors are being taken. Medication should not be changed, when antiretroviral treatment is adequate. To reduce the symptoms low-fat diet should be tried, as well as administration of HMG-CoA-reductase inhibitors or, if necessary, surgical liposuction.
引用
收藏
页码:1512 / 1516
页数:5
相关论文
共 19 条
[1]  
BRAUNFALCO O, 1996, DERMATOL VENEROL, P1381
[2]   Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].
Carr, A ;
Samaras, K ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1998, 351 (9119) :1881-1883
[3]  
ENZI G, 1986, MEDICINE, V64, P380
[4]   LIPIDS, LIPOPROTEINS, TRIGLYCERIDE CLEARANCE, AND CYTOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
GRUNFELD, C ;
PANG, MY ;
DOERRLER, W ;
SHIGENAGA, JK ;
JENSEN, P ;
FEINGOLD, KR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) :1045-1052
[5]   Benign symmetric lipomatosis associated with protease inhibitors [J].
Hengel, RL ;
Watts, NB ;
Lennox, JL .
LANCET, 1997, 350 (9091) :1596-1596
[6]   MULTIPLE SYMMETRICAL LIPOMATOSIS - ABNORMALITIES IN COMPLEX-IV AND MULTIPLE DELETIONS IN MITOCHONDRIAL-DNA [J].
KLOPSTOCK, T ;
NAUMANN, M ;
SCHALKE, B ;
BISCHOF, F ;
SEIBEL, P ;
KOTTLORS, M ;
ECKERT, P ;
REINERS, K ;
TOYKA, KV ;
REICHMANN, H .
NEUROLOGY, 1994, 44 (05) :862-866
[7]  
Kovacs A, 1997, CHIRURG, V68, P276, DOI 10.1007/s001040050188
[8]   MULTIPLE SYMMETRICAL LIPOMATOSIS (LAUNOIS-BENSAUDE SYNDROME) - EFFECT OF ORAL SALBUTAMOL [J].
LEUNG, NWY ;
GAER, J ;
BEGGS, D ;
KARK, AE ;
HOLLOWAY, B ;
PETERS, TJ .
CLINICAL ENDOCRINOLOGY, 1987, 27 (05) :601-606
[9]   Buffalo hump in men with HIV-1 infection [J].
Lo, JC ;
Mulligan, K ;
Tai, VW ;
Algren, H ;
Schambelan, M .
LANCET, 1998, 351 (9106) :867-870
[10]   Clinical pharmacokinetics of fibric acid derivatives (fibrates) [J].
Miller, DB ;
Spence, JD .
CLINICAL PHARMACOKINETICS, 1998, 34 (02) :155-162